Anavex Life Sciences Corp (AVXL)

[poguemahone]

I guess if you're going back 4 years, then perhaps you are okay with where things stand. Since I've "only" been invested for 2.5 years (which places me in the "impatient" category according to some on the board), I am underwater by nearly 35% of my initial investment. Therefore, forgive me for not bowing just yet to our Sun God, Dr. Missling.

However, the market cap you state is not $150M, but actually about $133M. This may not sound like a big deal, but sometimes investment funds have market capitalization cutoffs, and $150M is sometimes an inflection point that decides whether they can/can't own a security. Even more of a concern is the PPS. Several funds have a minimum of a $5 PPS as a minimum amount that can be considered investment quality. Add to this that fact that at Merrill Edge, you cannot margin/or even purchase on margin securities below $10.

Based upon what I have stated above, think of the limited demand for a security such as this based upon some of these constraints. The longer this stock drifts downward, the less likely it ever recovers. Say what you will regarding what we may potentially have, but many great ideas "die on the vine" when execution is poor.

I want to believe that AVXL is on the precipice of a paradigm shift in biotechnology. I'm just having a hard time ignoring the reality of the SP erosion and lack of transparency coming from HQ.